AI assistant
Wockhardt Ltd — Regulatory Filings 2021
Jul 12, 2021
59231_rns_2021-07-12_ce254211-e396-4150-abef-5776ca8607fc.pdf
Regulatory Filings
Open in viewerOpens in your device viewer
9[th] July, 2021
==> picture [167 x 46] intentionally omitted <==
National Stock Exchange of India Limited
Listing Department Exchange Plaza Bandra Kurla Complex, Bandra (E), Mumbai - 400 051
NSE Symbol – WOCKPHARMA
Dear Sir/ Madam,
This is with reference to your communication dated 5[th] July, 2021, advising us to provide clarification with respect to our intimation dated 3[rd] July, 2021, regarding 'Incorporation of a subsidiary of Wockhardt Limited ( the Company ) - Wockhardt Biologics Limited’
In view of the above, we wish to clarify that the newly incorporated subsidiary i.e. Wockhardt Biologics Limited (‘WBL’), has been set up to carry out business in pharmaceutical industry.
Kindly take the same on record.
Thanking you,
for Wockhardt Limited
==> picture [114 x 43] intentionally omitted <==
Gajanand Sahu Company Secretary
==> picture [106 x 46] intentionally omitted <==
==> picture [482 x 30] intentionally omitted <==